STUDY OF THE EFFICACY OF TREATMENT OF MANIFEST IRON DEFICIENCY IN PREGNANT WOMEN WITH TARDIFERON

dc.contributor.author	F.K.Askarova
dc.date.accessioned	2025-12-31T15:36:07Z
dc.date.issued	2022-05-06
dc.description.abstract	Anemia is a decrease in the number of erythrocytes and hemoglobin in the blood. Abnormal forms of erythrocytes appear in the blood, as well as changes in the balance of vitamins, reduced number of trace elements and enzymes in the body. During pregnancy, a woman's blood volume increases by 50%, which require more hemoglobin and iron reserves. This is of great importance in the development of the placenta and the baby. Anemia is the most common condition in pregnancy.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/929
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/48942
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/929/832
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 10 (2022): WBPH; 32-34
dc.source	2749-3644
dc.subject	Anemia,
dc.subject	Tardiferone
dc.title	STUDY OF THE EFFICACY OF TREATMENT OF MANIFEST IRON DEFICIENCY IN PREGNANT WOMEN WITH TARDIFERON
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: fkaskarova_2022_study_of_the_efficacy_of_treatment_of_ma.pdf
item.page.filesection.size: 144.96 KB
item.page.filesection.format: Adobe Portable Document Format